Johnson & Johnson is prepared to “put dollars towards, quite frankly, baseless scientific claims” to settle litigation alleging the talc products it previously marketed are linked to cancer.
The firm on 18 April reiterated its stance on the safety of its talc as it reported that 7.4% growth...





